MAP4K4 and cervical cancer: The results revealed that the levels of SOX6 protein and its downstream MAP4K4 protein in the frozen cervical cancer tissues of patients who were sensitive to cisplatin were lower than those in patients who were not sensitive to cisplatin (Fig. 6G–I).